logo
#

Latest news with #KateWalsh

Kate Walsh Talks About Multi-Cancer Early Detection Testing
Kate Walsh Talks About Multi-Cancer Early Detection Testing

Forbes

time13-05-2025

  • Health
  • Forbes

Kate Walsh Talks About Multi-Cancer Early Detection Testing

Grey's Anatomy star Kate Walsh discussed her parents experiences with cancer and her own cancer ... More scare and the importance of detecting cancer early. (Photo: Courtesy of HelloMMC) Grey's Anatomy star Kate Walsh called this decision a 'no brainer' in both a serious and punny way. It's her decision to team up with the company GRAIL to advocate for more multi-cancer early detection testing in a campaign they're calling 'Generation Possible.' Now MCED, short for multi-cancer early detection, isn't exactly a term that's already bandied about regularly like 'OMG' or 'IYKYK.' It's a newer term that may at first sound quite technical. But breaking the term down to its component parts can help understand what it is. 'Cancer" along with 'early detection' means trying to catch cancer in its early stages before it's spread and becomes much more difficult to treat. 'Testing' implies some kind of test to do this. And "multi-cancer' means a test that can look for multiple different cancers at a time. This is in contrast to tests like mammography, colonoscopy or prostate specific antigen blood levels that look for cancer in just very specific parts of the body. You wouldn't, for example, use colonoscopy to look for lung cancer, unless you somehow weren't paying attention and inserted the scope in a very wrong place. Walsh is serious about the early detection of cancer in large part because of what happened to her parents. Her father was diagnosed with late stage lung cancer. 'It was not detected early enough and he succumbed unfortunately to cancer a year and a half later, quite young." Walsh recalled. "He was just three days short of his 61st birthday.' That was over three decades ago when Walsh herself was only 23. Her mother had a different experience with cancer. 'My mother survived breast cancer,' Walsh recalled in a recent conversation. 'She was diagnosed at 62, but they caught it early enough to where she had double mastectomy where she was able to live cancer-free for another 30 years. We were very fortunate.' Walsh also mentioned a good friend from high school who died of breast cancer. Here's the punny part. GRAIL now has a multicancer detection test that's commercially available. Walsh explained, 'This technology has never been available before, it was not there in my parents' generation,' hence the name of the campaign Generation Possible. 'It was a no brainer to work with GRAIL,' Walsh added. 'I should say pun not intended since I did have a brain tumor, which was very fortunately not cancerous, ten years ago.' Yes, Walsh had her own cancer scare in 2015, when Walsh was in her mid-40s. The first symptoms that came to a head, so to speak, were rather subtle. 'I was just exhausted and then I got more and more tired.' Her Pilates trainer then noticed that her right side was dipping. Not in a 'hip dip' Pilates move type of way. But in a what's-going-on type of way. It took a while for her to act on these various symptoms, which she attributed to 'American can-do and stoicism. I'm sure it's just, you know, tired. Or I just did a big TV show, I burned myself out. I was working out really hard I burned myself out.' But eventually after 'all these little subtle markers" got 'more and more pronounced,' she got an MRI of your brain. 'And then lo and behold I had a pretty sizable tumor in there," Walsh recounted. "So, three days later I was in surgery and had it had it out and thankfully they were able to get all of it and it was benign.' It turned out to be a meningioma. A meningioma is a non-cancerous overgrowth of the meninges, the tissues that wrap around the brain sort of like Saran Wrap around a tomato. Except that one's brain is a bit more important than a tomato. Kate Walsh starred as Dr. Addison Shephard in ABC TV's medical drama series "Grey's Anatomy." Here ... More she is pictured with Ellen Pompeo, who played Dr. Meredith Grey, and Patrick Dempsey, who played Dr. Derek Shepherd. (Photo by Craig Sjodin/Disney General Entertainment Content via Getty Images) In general, waiting for symptoms to appear before getting checked for cancer is not a good proposition. It's a bit like waiting for your house to fall into pieces before doing something about a termite infestation. Cancer is when some cells in your body start to grow abnormally in an uncontrolled manner. If you catch these calls early enough, you may be able to pluck them out or kill them before they spread anywhere else. In these early stages, though, many cancers don't cause any symptoms. Symptoms really start emerging after the cancer has spread, which, in turn, can significantly decrease the chances of successful treatment. It can be much tougher to get each and every cancer cell out of your body. On top of that, people can delay going to the doctor. After all, the words 'I have a doctor's appointment' aren't typically followed by a 'Woooo.' Even Walsh, who played Dr. Addison Montgomery in the TV series Grey's Anatomy and Private Practice, has had a very common reluctance to see doctors. 'For someone who played a doctor on TV for the better part of a decade and back and forth over the years, I never really liked going to the doctor,' Walsh said. 'I really did the bare minimum." After her mother was diagnosed with breast cancer, Walsh did start advocating for people to get cancer screenings such as mammograms. 'But I still get nervous and intimidated [during doctor's appointments],' Walsh related. 'I always say to people, bring your husband or wife or a partner or a friend to ask questions that you might forget to ask or take notes, because I think it's anxiety provoking, you know? It's not a friend to friend conversation. There's an awe about doctors.' When you don't go to the doctor regularly or are like a deer in headlights during the appointment, you may not end up getting screened for cancer properly. Currently, the American Cancer Society recommends the following: In addition, you can get screened for skin cancer with the doctor searching your body for suspicious looking stuff. If you notice, though, that's only a small fraction of the over 200 possible cancers that people could possibly get. For most other cancers, there historically has not been ways to detect them early. The Galleri test is now commercially available. GRAIL is seeking FDA approval of the test. (Photo: ... More Courtesy of GRAIL) That's prompted researchers to try to find some sort of detectable signal that is present across different cancers at their early stages. It's helpful to find something that is common in many different cancers because you want the screening to be as practical as possible. It could get a little daunting if a doctor were to say, 'OK, get ready for the over 100 different scopes to be inserted into different parts of your body.' It's also good to have tests as painless as possible. Because who wants more pain in life. All of these motivations have given rise to the MCED concept. GRAIL has been advocating for MCED because, naturally, they have a commercially available test aiming to do the MCED thing. GRAIL's Galleri test looks in blood samples for DNA fragments with certain methylation patterns suggestive of cancer. The test is based on the fact that all cells in your body, healthy or otherwise, shed their DNA to varying degrees. That can leave various fragments of DNA circulating through your bloodstream. These DNA fragments can be methylated to varying degrees. Methylation is when a methyl group consisting of carbon and hydrogen atoms gets attached to the DNA molecules in your cells. A cell uses such methylation to turn on and off sections of its DNA, in turn, changing what proteins the DNA codes for at the time. Josh Ofman, MD, MSHS, is president at GRAIL, chronicled how the concept behind the Galleri test arose by accident: 'It really dated back to 2015 at Ilumina. The origin story was they did a big study with about 125,000 pregnant women.' The study was part of Illumina's testing of their non-invasive prenatal test that entailed checking pregnant mothers for genomic abnormalities. 'There were 10 cases where the DNA just looked really abnormal,' said Ofman. 'The medical director at that time was a guy named Rick Klausner, who was the ex head of the National Cancer Institute, and he said you only see the abnormal DNA like this in cancer." Ofman continued with, "They called those 10 women back and all 10 of them had an asymptomatic cancer. And that's when the light bulbs went off in Illumina.' Illumina subsequently spun out GRAIL to develop the technology that could test for DNA fragments with methylation patterns that are indicative of cancer. That eventually led to the Galleri test that was launched as a commercial product in 2021. A big test of the test conducted from the end of 2019 through 2020 was the PATHFINDER study, a prospective cohort study of 6,662 folks 50 years of age and above who didn't have at the time symptoms suggestive of cancer. Results from PATHFINDER as described in a GRAIL press release alongside a publication in The Lancet in 2023 found the test to be 97% accurate in detecting cancer. Now, commercially available doesn't necessarily mean readily financially available to everyone. While you or your employer can currently pay for the test if either of you have the cash to shell out, insurance typically won't cover it yet. Ofman said that they are in the process of trying to get FDA approval of Galleri, 'Where we hope to become the first multi early detection test that has an FDA approval.' Of course, GRAIL isn't the only place working on MCED stuff. Other scientists around the world are trying to find different ways to catch more cancers earlier and more efficiently with less invasiveness. There is a big need for such things as cancer is one of the leading causes of death around the world, accounting for nearly one in six of all deaths, according to the World Health Organization. And the rates of cancers like prostate cancer continue to rise, especially among younger people. Therefore, it is a 'no brainer' to want more ways to detect more different cancers earlier as Kate Walsh does. It is also a 'no brainer' to ensure that more people get access to cancer screening technology. With further scientific research—assuming that science gets the proper amount of support and funding—and more support of screening tests, all of these things may become increasingly possible for the current generations and beyond.

Nonprofit may pick up Commonwealth Care Alliance business
Nonprofit may pick up Commonwealth Care Alliance business

Yahoo

time07-04-2025

  • Business
  • Yahoo

Nonprofit may pick up Commonwealth Care Alliance business

BOSTON (SHNS) – With insurance provider Commonwealth Care Alliance at risk of an impending financial collapse, Health and Human Services Secretary Kate Walsh said Monday that the state will have 'very good news' this week for the 46,000 low-income and disabled Bay Staters who rely on it and teased that a different provider plans to expand into Massachusetts to fill the gap. 'They are, in their current corporate form, really struggling from a financial standpoint. We have spent, and the MassHealth team has spent, enormous amounts of time working to try to stabilize that insurance plan,' Walsh said at a budget hearing in Attleboro on Monday. Walsh added, 'We encouraged everybody we could find to look at that program, and most people were quite dismayed about what they saw about their financial management. We have been working with a potential solution, working very hard to get a potential solution to that problem.' CCA insures about 46,000 disabled and low-income people in Massachusetts, Walsh said, and it also functions as a service provider for some of the people it serves. Its financial picture is in bad shape after the company expanded its model from Massachusetts into four other states 'where they lost their shirt,' the secretary said. The Boston Globe has previously reported on the state's efforts to prepare for a potential collapse of CCA. 'I think we'll have very good news this week on that,' Walsh told the Joint Ways and Means Committee. 'So that the 46,000 people who have relied on that insurance plan will go into a different plan that will have many of the same characteristics. It will be not-for-profit, it will be very experienced in caring for people with these kinds of challenges. Their references from other states are excellent, so fingers crossed.' Walsh did not provide additional details, but said the company being tapped to take over the CCA population 'will expand into Massachusetts.' CCA declined to comment Monday on Walsh's comments or the impending announcement. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

State orders open access to free prenatal vitamins, birth control
State orders open access to free prenatal vitamins, birth control

Yahoo

time06-03-2025

  • Health
  • Yahoo

State orders open access to free prenatal vitamins, birth control

BOSTON (SHNS) – Eligible MassHealth members and Health Safety Net patients will have access to prenatal vitamins and over-the-counter birth control at no cost, under two standing orders that the Healey administration announced Thursday. The orders, which essentially enable the state to write a prescription for a large group of people, will allow about half a million patients to access the reproductive health medications. The medications will be available at all MassHealth-enrolled pharmacies, and available for eligible MassHealth members and those who use the Health Safety Net, a fund used to pay care costs for certain low-income and uninsured individuals. MassHealth currently covers 40 percent of all births in Massachusetts, according to the Healey administration. 'Removing barriers like this is one of the simplest ways we can work toward better health outcomes for mothers and infants in our state,' Health and Human Services Secretary Kate Walsh said. The standing order covers a 90-day supply of over-the-counter prenatal vitamins or multivitamins containing at least 400 mcg of folic acid, a B vitamin that helps bodies create new cells. Doctors recommend that people considering getting pregnant, pregnant, or nursing, take these vitamins. Pharmacists will be required to counsel patients on the use of prenatal vitamins, including when to start and stop taking them, and encourage follow-up with a primary care provider and obstetrician/gynecologist. The second standing order covers oral hormonal contraceptives. It allows pharmacists to give out a 365-day supply of over-the-counter birth control pills — specifically norgestrel 0.075 mg tablets — to eligible MassHealth members and HSN patients. It specifies that birth control is 'accessible to individuals of reproductive potential and age,' according to Healey's Executive Office of Health and Human Services. 'As part of this initiative, pharmacists will be required to counsel patients on contraindications, side effects, and the proper use of the birth control pill, emphasizing the importance of daily adherence and informing patients that the pill does not protect against sexually transmitted infections,' information from EOHHS says. 'We know that prenatal vitamins and birth control play an essential role in women's health. No one should be prevented from getting the care they need because of cost or because they are waiting for a prescription,' Healey said in a statement. 'These standing orders will make it easier and more affordable for people to make the best health care decisions for themselves, will improve health outcomes for women and babies, and will reduce health disparities.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

'Grey's Anatomy' star Kate Walsh shares 'very subtle' warning signs ahead of brain tumor diagnosis
'Grey's Anatomy' star Kate Walsh shares 'very subtle' warning signs ahead of brain tumor diagnosis

Fox News

time02-03-2025

  • Health
  • Fox News

'Grey's Anatomy' star Kate Walsh shares 'very subtle' warning signs ahead of brain tumor diagnosis

"Grey's Anatomy" star Kate Walsh is opening up about a health scare she faced years ago. During a recent appearance on "The Kelly Clarkson Show," the 57-year-old actress recalled being diagnosed with a noncancerous brain tumor in 2015 and shared how the experience changed her approach to health. "Thankfully, it turned out to be benign, so I was very, very fortunate," Walsh said. The "Private Practice" alum explained she noticed "very subtle" warning signs ahead of her diagnosis. "It was like, 'Hey, I'm really tired,'" Walsh recalled. "And then it's like, 'Oh, the right side of my body is dipping.'" Walsh told Clarkson she was uncertain if she had a health problem at the time, since people around her were initially dismissive of her concerns. "They're like, 'Oh, you're off.' I'm like, 'No,'" she said. "And then, walking the dog, I'm like, 'It must be a little bit of a windy street.' "It was just sort of very subtle and then very kind of, 'Oh it's ADD. I can't really focus. Oh, I've been scrolling too much.' That kind of stuff." Walsh continued to worry about her symptoms and decided to seek medical attention. Looking back, the California native shared that she learned a valuable lesson from the experience. "I know how important it is to advocate for one's own health because people were like, 'You're just depressed.' It was right after [my TV show] 'Bad Judge' got canceled,'" Walsh recalled. "Your show got canceled. You're just depressed,'" she remembered people telling her. "I'm like, 'No, something's off.'" Walsh first revealed her brain tumor diagnosis in a September 2017 interview with Cosmopolitan. The "Emily in Paris" actress told the outlet she had physical and cognitive problems before doctors discovered a tumor in her brain the size of a small lemon. Walsh told the outlet she initially believed her symptoms were due to menopause, noting "there are a lot of the same markers." "I know how important it is to advocate for one's own health because people were like, 'You're just depressed.'" "I really pushed to see a neurologist. I just had an instinct," she recalled. "I had to really advocate because they don't hand out MRIs so easily. But I got an MRI and, thank God I did, because it turned out I had a very sizable brain tumor in my left frontal lobe." Walsh told the outlet she was stunned after receiving her diagnosis. "I just left my body," she said. "My assistant had driven me there, and I had to go get him so that he could take notes because I was gone. It was never anything I would have imagined." Three days later, Walsh had surgery to remove the growth, and it was later determined to be a benign meningioma. According to the Mayo Clinic, meningiomas are "brain tumors that start in the membranes around the brain and spinal cord" and they are the most common type of benign brain tumors. While appearing on "The Kelly Clarkson Show," Walsh shared that she has a family history of cancer. Her father died due to complications from lung cancer, and her mother was a breast cancer survivor. The actress emphasized the importance of early detection and screening but acknowledged that it can be difficult for people to speak out about their health concerns. "It's a hard thing when you have everybody looking at you going, 'Hmm, I think you're just this or that. You're tired.'"

Kate Walsh recalls ‘very subtle' symptoms that led to brain tumor diagnosis: ‘Something's off'
Kate Walsh recalls ‘very subtle' symptoms that led to brain tumor diagnosis: ‘Something's off'

Yahoo

time01-03-2025

  • Health
  • Yahoo

Kate Walsh recalls ‘very subtle' symptoms that led to brain tumor diagnosis: ‘Something's off'

Kate Walsh learned an important life lesson from a health scare she encountered in 2015. While appearing on "The Kelly Clarkson Show" on Feb. 27, the actor recalled being diagnosed with a brain tumor in 2015 and explained how the experience affected her outlook on health. "Thankfully, it turned out to be benign, so I was very, very fortunate," she said. Walsh, 57, went on to share some of the warning signs that led to her diagnosis. "It was like, 'Hey, I'm really tired.' And then it's like, 'Oh, the right side of my body is dipping,'" she recalled. At first, Walsh wasn't sure what was going on, especially since people kept telling her she was fine. "They're like, 'Oh, you're off.' I'm like 'No,'" she said. Walsh also felt strange while walking her dog one day and recalled thinking the street must be "windy." "It was just sort of very subtle and then very kind of, 'Oh it's ADD. I can't really focus. Oh I've been scrolling too much.' That kind of stuff," she said. Going through this health scare taught Walsh a lesson that she's hoping to share with others. "I know how important it is to advocate for one's own health because people were like, You're just depressed.' It was right after (my TV show) 'Bad Judge' got canceled. 'Your show got canceled. You're just depressed,'" she recalled others saying. "I'm like, 'No something's off.'" Still, Walsh acknowledged that it's challenging to advocate for yourself in these scenarios. "It's a hard thing when you have everybody looking at you going, 'Hmm, I think you're just this or that. You're tired,'" she said. In 2017, Walsh appeared on TODAY to discuss her diagnosis and recovery. After feeling 'exhausted,' she decided to seek medical assistance. 'But I'd just wrapped a show, 'Bad Judge,' and I was starring in it and executive producing, so it wasn't unheard of to be totally exhausted. So I thought I just really burned myself out.' Soon enough, Walsh started experiencing cognitive symptoms and "couldn't find my words." After fighting for a diagnostic MRI, Walsh learned that she had a 'very sizable tumor.' Following a surgery, she discovered that it was benign. The non-cancerous tumor was known as a meningioma, which John Hopkins Medicine defines as "the most common type of primary brain tumor." "These tumors originate in the meninges, which are the outer three layers of tissue between the skull and the brain that cover and protect the brain just under the skull," the John Hopkins Medicine website reads. "Meningiomas grow out of the middle layer of the meninges called the arachnoid. They grow slowly and may exist for years before being detected." This article was originally published on

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store